In this multicenter study, we will recruit 400 patients 40 years of age or older at 15 centers with a diagnosis of smoldering multiple myeloma (SMM), a group of patients for whom standard of care is observation not treatment. The main goal of this study is to screen for the diagnosis of light-chain amyloidosis (AL) before the onset of symptomatic disease and to develop a training set for a likelihood algorithm.
Smoldering Multiple Myeloma
In this multicenter study, we will recruit 400 patients 40 years of age or older at 15 centers with a diagnosis of smoldering multiple myeloma (SMM), a group of patients for whom standard of care is observation not treatment. The main goal of this study is to screen for the diagnosis of light-chain amyloidosis (AL) before the onset of symptomatic disease and to develop a training set for a likelihood algorithm.
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
-
University of Alabama Hospital, Birmingham, Alabama, United States, 35233
Cedars-Sinai Medical Center, Los Angeles, California, United States, 90048
University of California, Irvine, Orange, California, United States, 92868
University of California, San Francisco, San Francisco, California, United States, 94143
Cleveland Clinic Florida, Weston Hospital, Weston, Florida, United States, 33331
Tufts Medical Center, Boston, Massachusetts, United States, 02111
Columbia University Irving Medical Center, New York, New York, United States, 10032
Memorial Sloan Kettering Cancer Center, New York, New York, United States, 10065
Atrium Health Levine Cancer Institute, Charlotte, North Carolina, United States, 28204
UNC Lineberger Comprehensive Cancer Center, Durham, North Carolina, United States, 27705
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
40 Years to
ALL
No
Tufts Medical Center,
2029-02-27